Reports - Stem Cell Therapy Market
HealthcareStem Cell Therapy Market
Stem Cell Therapy Market Size | Industry Report, 2035 by Type (Allogeneic, Autologous) by Cell Source (Adipose Tissue-derived MSCs (Mesenchymal Stem Cells), Bone Marrow-derived MSCs, Others Cell Sources) by Therapeutic Application (Musculoskeletal Disorders, Wounds & Injuries, Surgeries, Inflammatory & Autoimmune Diseases, Neurological Disorders, Other Therapeutic Applications) by Region (North America, Europe, Asia Pacific, Latin America, Middle East & Africa
Industry Leaders Trust Us For Actionable Intelligence
Table of Contents
Chapter 1 Executive Dashboard
1. Strategic Imperatives
Chapter 2 Premium Insights
1. Top 3 Trends to Watch
2. Demand and Supply Trends
3. Top 3 Strategies Followed by Major Players
4. Top 3 Predictions by Vantage Market Research
5. Top Investment Pockets
6. Insights from Primary Respondents
Chapter 3 Global Stem Cell Therapy Market - Segment Analysis
1. Overview
2. Global Stem Cell Therapy Market, 2021 - 2035 (USD Million)
3. Global Stem Cell Therapy Market - by Type
3.1. By Allogeneic
3.2. By Autologous
4. Global Stem Cell Therapy Market - by Cell Source
4.1. By Adipose Tissue-derived MSCs (Mesenchymal Stem Cells)
4.2. By Bone Marrow-derived MSCs
4.3. By Others Cell Sources
5. Global Stem Cell Therapy Market - by Therapeutic Application
5.1. By Musculoskeletal Disorders
5.2. By Wounds & Injuries
5.3. By Surgeries
5.4. By Inflammatory & Autoimmune Diseases
5.5. By Neurological Disorders
5.6. By Other Therapeutic Applications
6. Global Stem Cell Therapy Market - by region
6.1. North America
6.2. Europe
6.3. Asia Pacific
6.4. Latin America
6.5. Middle East & Africa
7. Market comparative analysis
Chapter 4 North America Stem Cell Therapy Market - Segment Analysis
1. Overview
2. North America Stem Cell Therapy Market, 2021 - 2035 (USD Million)
3. North America Stem Cell Therapy Market - by Type
3.1. By Allogeneic
3.2. By Autologous
4. North America Stem Cell Therapy Market - by Cell Source
4.1. By Adipose Tissue-derived MSCs (Mesenchymal Stem Cells)
4.2. By Bone Marrow-derived MSCs
4.3. By Others Cell Sources
5. North America Stem Cell Therapy Market - by Therapeutic Application
5.1. By Musculoskeletal Disorders
5.2. By Wounds & Injuries
5.3. By Surgeries
5.4. By Inflammatory & Autoimmune Diseases
5.5. By Neurological Disorders
5.6. By Other Therapeutic Applications
Chapter 5 Europe Stem Cell Therapy Market - Segment Analysis
1. Overview
2. Europe Stem Cell Therapy Market, 2021 - 2035 (USD Million)
3. Europe Stem Cell Therapy Market - by Type
3.1. By Allogeneic
3.2. By Autologous
4. Europe Stem Cell Therapy Market - by Cell Source
4.1. By Adipose Tissue-derived MSCs (Mesenchymal Stem Cells)
4.2. By Bone Marrow-derived MSCs
4.3. By Others Cell Sources
5. Europe Stem Cell Therapy Market - by Therapeutic Application
5.1. By Musculoskeletal Disorders
5.2. By Wounds & Injuries
5.3. By Surgeries
5.4. By Inflammatory & Autoimmune Diseases
5.5. By Neurological Disorders
5.6. By Other Therapeutic Applications
Chapter 6 Asia Pacific Stem Cell Therapy Market - Segment Analysis
1. Overview
2. Asia Pacific Stem Cell Therapy Market, 2021 - 2035 (USD Million)
3. Asia Pacific Stem Cell Therapy Market - by Type
3.1. By Allogeneic
3.2. By Autologous
4. Asia Pacific Stem Cell Therapy Market - by Cell Source
4.1. By Adipose Tissue-derived MSCs (Mesenchymal Stem Cells)
4.2. By Bone Marrow-derived MSCs
4.3. By Others Cell Sources
5. Asia Pacific Stem Cell Therapy Market - by Therapeutic Application
5.1. By Musculoskeletal Disorders
5.2. By Wounds & Injuries
5.3. By Surgeries
5.4. By Inflammatory & Autoimmune Diseases
5.5. By Neurological Disorders
5.6. By Other Therapeutic Applications
Chapter 7 Latin America Stem Cell Therapy Market - Segment Analysis
1. Overview
2. Latin America Stem Cell Therapy Market, 2021 - 2035 (USD Million)
3. Latin America Stem Cell Therapy Market - by Type
3.1. By Allogeneic
3.2. By Autologous
4. Latin America Stem Cell Therapy Market - by Cell Source
4.1. By Adipose Tissue-derived MSCs (Mesenchymal Stem Cells)
4.2. By Bone Marrow-derived MSCs
4.3. By Others Cell Sources
5. Latin America Stem Cell Therapy Market - by Therapeutic Application
5.1. By Musculoskeletal Disorders
5.2. By Wounds & Injuries
5.3. By Surgeries
5.4. By Inflammatory & Autoimmune Diseases
5.5. By Neurological Disorders
5.6. By Other Therapeutic Applications
Chapter 8 Middle East & Africa Stem Cell Therapy Market - Segment Analysis
1. Overview
2. Middle East & Africa Stem Cell Therapy Market, 2021 - 2035 (USD Million)
3. Middle East & Africa Stem Cell Therapy Market - by Type
3.1. By Allogeneic
3.2. By Autologous
4. Middle East & Africa Stem Cell Therapy Market - by Cell Source
4.1. By Adipose Tissue-derived MSCs (Mesenchymal Stem Cells)
4.2. By Bone Marrow-derived MSCs
4.3. By Others Cell Sources
5. Middle East & Africa Stem Cell Therapy Market - by Therapeutic Application
5.1. By Musculoskeletal Disorders
5.2. By Wounds & Injuries
5.3. By Surgeries
5.4. By Inflammatory & Autoimmune Diseases
5.5. By Neurological Disorders
5.6. By Other Therapeutic Applications
Chapter 9 Key Market Dynamics
1. Introduction
2. Market Drivers
3. Market Restraints
4. Market Opportunities
5. Porter's Five Forces Analysis
6. PEST Analysis
7. Regulatory Landscape
8. Technology Landscape
9. Regional Market Trends
Chapter 10 COVID 19 Impact Analysis
1. Key strategies undertaken by companies to tackle COVID-19
2. Short term dynamics
3. Long term dynamics
Chapter 11 Marketing Strategy Analysis
1. Marketing Channel
2. Direct Marketing
3. Indirect Marketing
4. Marketing Channel Development Trends
Chapter 12 Competitive Landscape
1. Competition Matrix - 2021
2. Company Market Share Analysis - 2021
3. Key Company Activities, 2018 - 2021
4. Strategic Developments - Heat Map Analysis
5. Company Offering Evaluation
6. Company Regional Presence Evaluation
Chapter 13 Company Profiles
1. Advanced Cell Technology Inc. (U.S.)
2. Caladrius Biosciences (U.S.)
3. Angel Biotechnology (Scotland)
4. Bioheart Inc. (U.S.)
5. Brainstorm Cell Therapeutics (U.S.)
6. Celgene Corporation (U.S.)
7. Cellartis AB (Sweden)
8. CellGenix GmbH (Germany)
9. Cellular Engineering Technologies Inc. (U.S.)
10. Gamida Cell (Israel)
11. Genea Biocells (U.S.)
12. Osiris Therapeutics (U.S.)
13. PromoCell GmbH (Germany)
14. STEMCELL Technologies Inc. (Canada)
15. Tigenix Waisman Biomanufacturing (U.S.)
16. Kite Pharma (U.S.)
17. Lonza (Switzerland)
Chapter 14 Key Primary Respondents - VERBATIM
Chapter 15 Discussion Guide
Chapter 16 Customization Offered
Chapter 17 Annexure
Chapter 18 List of Figures
Chapter 19 List of Tables
Chapter 20 List of Abbreviations
FAQ‘s
Related Reports
Contact
Toll Free Number+1 (877) 462-2282
© 2025 Vantage Market Research. All right reserved
Secured By